0001144204-16-140279.txt : 20161219 0001144204-16-140279.hdr.sgml : 20161219 20161219164840 ACCESSION NUMBER: 0001144204-16-140279 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161219 DATE AS OF CHANGE: 20161219 EFFECTIVENESS DATE: 20161219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inspyr Therapeutics, Inc. CENTRAL INDEX KEY: 0001421204 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-276592 FILM NUMBER: 162059453 BUSINESS ADDRESS: STREET 1: 2511 N LOOP 1604 W STREET 2: SUITE 204 CITY: SAN ANTONIO STATE: TX ZIP: 78258 BUSINESS PHONE: (210) 479-8112 MAIL ADDRESS: STREET 1: 2511 N LOOP 1604 W STREET 2: SUITE 204 CITY: SAN ANTONIO STATE: TX ZIP: 78258 FORMER COMPANY: FORMER CONFORMED NAME: GENSPERA INC DATE OF NAME CHANGE: 20071213 D 1 primary_doc.xml X0707 D LIVE 0001421204 Inspyr Therapeutics, Inc. 31200 VIA COLINAS SUITE 200 WESTLAKE VILLAGE CA CALIFORNIA 91362 818-661-6302 DELAWARE GenSpera, Inc. GENSPERA INC Corporation true Christopher Lowe 31200 Via Colinas Suite 200 Westlake Village CA CALIFORNIA 91362 Executive Officer Director Russell Richerson 31200 Via Colinas Suite 200 Westlake Village CA CALIFORNIA 91362 Executive Officer Ronald Shazer 31200 Via Colinas Suite 200 Westlake Village CA CALIFORNIA 91362 Executive Officer Bo Jesper Hansen 31200 Via Colinas Suite 200 Westlake Village CA CALIFORNIA 91362 Director Peter Grebow 31200 Via Colinas Suite 200 Westlake Village CA CALIFORNIA 91362 Director Scott Ogilvie 31200 Via Colinas Suite 200 Westlake Village CA CALIFORNIA 91362 Director Richard Buller 31200 Via Colinas Suite 200 Westlake Village CA CALIFORNIA 91362 Director Claire Thom 31200 Via Colinas Suite 200 Westlake Village CA CALIFORNIA 91362 Director Pharmaceuticals No Revenues 06b false 2016-12-15 false true true true false 10000 Rodman & Renshaw, LLC 281264 H.C. Wainwright & Co., LLC 375 430 PARK AVENUE NEW YORK NY NEW YORK 10022 All States false 1200000 1000000 200000 false 5 120000 0 Does not include 133,334 placement agent warrants with exercise price of $0.30 and term of five years. Additionally does not include additional compensation to placement agents upon exercise of investor warrants. 0 true false Inspyr Therapeutics, Inc. /S/ Christopher Lowe Christopher Lowe Chief Executive Officer 2016-12-19